Clinical and Histological Study of a Novel Dermal Substitute
Clinical and Histological Study of a Novel Dermal Substitute, NovoSorb® BTM, Used in the Treatment of Full-thickness Skin Defects
University Children's Hospital, Zurich
42 participants
Jan 15, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to compare a novel dermal substitute to a the current standard procedure in the treatment of full thickness skin defects. The main questions aim to answer are: • Is the skin elasticity treated with the novel dermal substitute better than the skin elasticity treated with the current standard procedure Participants skin elasticity will be measured by Cutometer® MPA-580 assessment.
Eligibility
Inclusion Criteria6
- Age: 1 to 75 years
- Full-thickness skin defect qualifying for coverage with the dermal substitute NovoSorb® BTM before transplantation with a STSG:
- Acute cases: burn injury, soft tissue injury, skin necrosis after purpura fulminans or similar condition
- Reconstructive cases (elective surgery): e.g. scar formation after burn injury, giant congenital nevus, defect after removal of skin tumor, skin defect due to other surgical procedures
- Documented medical treatment decision of covering the full-thickness skin defects with either the two-step BTM/STSG procedure or with STSG alone or by using both techniques on different wound areas
- Informed consent by patients/parents or other legal representative
Exclusion Criteria5
- Infected wounds needing surgical procedure other than a dermal template
- Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. immune deficiency, systemic skin disease, any kind of congenital defect of metabolism including diabetes)
- Previous enrolment of the patient into the current study
- Adolescent/Adult patients or in case of children their parents/legal representatives unable to comply with the study protocol
- Pregnant or breast feeding females
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard of care
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06255990